In Alzheimer’s disease (AD), the ratio between two types of amyloid-beta, a protein in the brain, diverges from a normal level. On June 6, 2013, ISRAEL21c reported that Inna Slutsky, PhD, successfully used electrical pulses to the hippocampus restore that ratio to a healthy level from one associated with AD in a mouse model. Dr. Slutsky and her colleagues hypothesize that this may lead to a treatment for AD in humans. Dr. Slutsky is a principle investigator at Sagol School of Neuroscience, Tel Aviv University, Israel, and was the recipient of a 2008 Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's Disease.
Learn more about Alzheimer’s disease at the Infoaging Alzheimer’s Disease Center.
